ALAthanasia Liozidou

Athanasia Liozidou

*This is an algorithmically generated author record based on publicly available information.

Athanasia Liozidou has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the Personalisation of Digital Cognitive Rehabilitation in Multiple Sclerosis Through Wearable Data and Machine Learning

    by Georgios Nomikos, Antonios Billis, Alexandra Anagnostopoulou, Alexandros Moraitopoulos, Georgios Petridis, Maria Karagianni, Nefeli Tsoukaki, Ioannis Nikolaidis, Athanasia Liozidou, Nikolaos Grigoriadis, et al.

    Cognitive impairment is a frequent, disabling symptom of multiple sclerosis (MS). Digital interventions may help people with MS maintain or improve cognition, but effectiveness varies between individuals. This exploratory study examines the feasibility of using machine learning models trained on Fitbit-derived real-world data to predict responsiveness to a computerised cognitive training intervention. Linear support vector machine classifiers achieved a mean balanced accuracy of 0.71 in distinguishing responders from non-responders, while SHAP analysis identified sleep and cardiac activity features as key behavioural predictors. y linking real-world behavioural metrics with cognitive outcomes, this work shows how artificial intelligence and wearables may personalise neurorehabilitation and bridge the gap between data and precision care in MS.

  • Open Access

    In Vivo Mapping of Catecholaminergic Loss and Iron Deposition in Huntington's Disease

    by Edoardo R. de Natale, Heather Wilson, Efstratios Karavasilis, Athanasia Liozidou, Chrisoula Kartanou, Georgios Velonakis, Jens Kuhle, Ioannis Zalonis, Georgia Karadima, Leonidas Stefanis, et al.

    Background: The pathophysiology of Huntington's disease (HD) remains obscure. Magnetic resonance imaging (MRI) can reveal in vivo molecular changes related to disease pathology. Objectives: To investigate catecholaminergic neuronal integrity and subcortical brain iron accumulation in HD employing neuromelanin‐sensitive MRI, and quantitative susceptibility mapping (QSM‐MRI). Methods: Twenty‐five HD gene expansion carriers (HDGECs; 11 premanifest, mean predicted phenoconversion time 21.25 ± 8.28 years) and 25 healthy controls (HC) underwent clinical investigation, measurement of plasma neurofilament light chain (NfL) levels, neuromelanin‐sensitive, and QSM‐MRI on a 3 T scanner. For neuromelanin analysis, the substantia nigra (SN) and locus coeruleus (LC) areas and contrast‐to‐noise ratio (CNR) were computed. Regions of interest from the MuSus100 atlas were segmented for QSM‐MRI analysis, and susceptibility values extracted using the whole brain mask as reference. Results: Manifest HDGECs showed, on neuromelanin‐sensitive MRI analysis, reduced LC and SN areas, and LC CNR compared with HC ( P < 0.001). QSM analysis demonstrated increased susceptibility values in caudate, putamen, external and internal pallidum, and the subthalamic nucleus of manifest HGDECs ( P < 0.001). Higher susceptibility values in these regions correlated with clinical markers of disease burden, higher plasma NfL, and poorer neuropsychological outcomes in multiple domains ( P < 0.05). Smaller LC area correlated with higher plasma NfL ( P = 0.029). Higher susceptibility values in the caudate and putamen correlated with lower SN CNR ( P < 0.05). Conclusions: Our findings confirm widespread iron subcortical accumulation in HD, reveal significant noradrenergic neuronal loss, and describe dopaminergic alteration which may reflect ongoing pathology along the nigrostriatal pathway. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

  • Open Access

    Review of: "Sociodemographic, Clinical, and Psychological Barriers to Medication Compliance: The Case of Patients with Musculoskeletal Disorders in Greece"

    by Athanasia Liozidou

    This is very interesting research work that has sought to investigate a clinical topic of imperative importance regarding the treatment and therapeutic course of patients, given that non-compliance with medication is a severe factor in remissions, ho...

  • Open Access

    The Greek translation and validation of the electronic version of the Meno-D rating scale for post-menopausal depression

    by Georgios Papazisis, Ιoannis Tsakiridis, Aikaterini Apostolopoulou, Efstathios Papaefstathiou, Thalia Bellali, Athanasia Liozidou, Athanasia Pappa, Alexandra Ainatzoglou, Maria Tzitiridou, Antonis Billis, et al.

    Menopausal transition and post-menopause constitute windows of increased vulnerability to depression. Recently, the Meno-D was introduced, a novel 12-item, with five distinct subscales. The aim of our study was to translate and validate the electronic version of the Meno-D among Greek post-menopausal women. Translation and back-translation were performed by an expert group, while face validity was assessed by five experts. Along with the Beck Depression Inventory-II, the Meno-D scale was distributed online to 502 post-menopausal women. A confirmatory factor analysis was performed to investigate construct validity and both convergent and discriminant validity were evaluated. The data analysis was performed using Statistical Package for Social Sciences and AMOS. The 5-factor model of Meno-D achieved adequate levels of goodness-of-fit indices, scoring lower values in discriminant validity examined with heterotrait-monotrait ratio and composite reliability. The significant correlation with the Beck Depression Inventory-ΙΙ revealed for all subscales was indicative of good convergent validity. An exploratory factor analysis was additionally performed, suggesting a 12-item tool comprising two subscales: (i) psychological and (ii) biological and achieving good levels of fit. Our data confirmed that the electronic version of Meno-D is a valid tool that can be used for screening and evaluation of depression in Greek post-menopausal women.